FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,636,000 | +13.1% | 40,000 | 0.0% | 0.23% | -17.7% |
| Q1 2017 | $1,446,000 | -27.8% | 40,000 | 0.0% | 0.28% | -44.2% |
| Q4 2016 | $2,004,000 | -36.4% | 40,000 | -33.3% | 0.51% | -1.2% |
| Q3 2016 | $3,149,000 | +26.9% | 60,000 | 0.0% | 0.51% | -20.3% |
| Q2 2016 | $2,481,000 | -23.7% | 60,000 | -25.0% | 0.64% | -8.5% |
| Q1 2016 | $3,250,000 | -46.0% | 80,000 | -44.8% | 0.70% | -20.1% |
| Q4 2015 | $6,018,000 | +123.5% | 145,000 | -17.1% | 0.88% | +156.1% |
| Q3 2015 | $2,693,000 | -13.3% | 175,000 | +40.0% | 0.34% | +13.2% |
| Q2 2015 | $3,105,000 | +75.5% | 125,000 | +38.9% | 0.30% | -24.8% |
| Q1 2014 | $1,769,000 | – | 90,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |